Eurazeo : Patrimoine supports the acquisition of the Belledonne clinic by C2S Group

EURAZEO PATRIMOINE SUPPORTS THE ACQUISITION OF THE

BELLEDONNE CLINIC BY C2S GROUP

Paris, May 23, 2019 - Eurazeo Patrimoine, Eurazeo's investment division specializing in real estate and companies holding and operating real assets, announces the acquisition of the Belledonne Clinic, located near Grenoble (Isère, France) by C2S Group.

Created in 1967 in Saint-Martin-d'Hères, near Grenoble, the Belledonne Clinic offers a diversified and comprehensive range of medical services organized around seven activity sectors and particularly, cardiology, cancer surgery and maternity services. It has a capacity of 290 medical beds and 23 procedure rooms, thus becoming C2S Group's largest clinic. Its reputation is regularly upheld by national private hospitals rankings.

With over 1,900 beds and places and an annual revenue of around €250 million, C2S Group is a major private hospital player in France. It is present in the Rhône-Alpes Auvergne and Bourgogne Franche- Comté regions, where it has 14 clinics. C2S Group comprises around 710 doctors, who are partners in the Group's governance, and nearly 2,500 employees. Through its presence in the Center-East region, combining state-of-the-art and local establishments, C2S Group clinics treat over 300,000 patients each year.

Eurazeo Patrimoine has supported C2S's development since its acquisition in March 2018, backing the Group's external growth policy and helping it invest in capacity and modernization to strengthen the quality and attractiveness of its clinics. Eurazeo Patrimoine contributes financial and human resources and its investment and real estate transformation experience. The integration of the Belledonne Clinic in the Group forms part of this strategy and is a major step in C2S's development, confirming its position as a key player in the Center-East region.

Renaud Haberkorn, Director of Eurazeo Patrimoine said: "We're delighted to support C2S in its acquisition of the Belledonne Clinic, a top-tier asset both on operations and real estate level. The management team has demonstrated its ability to rapidly expand the Group, both organically and through instrumental acquisitions. Eurazeo Patrimoine supports and encourages C2S Group to achieve its ambitions."

Jean Rigondet, Chairman of C2S Group, added: "It is essential for patients to be treated by talented practitioners, working together as a team, and to have access to well-organized and broad medical care. The acquisition of the Belledonne Clinic provides us with a high-level, comprehensive technical platform in Greater Grenoble. We're extremely proud to integrate this reference clinic into our Group."

***

About Eurazeo

1. Eurazeo is a leading global investment company, with a diversified portfolio of €17 billion in assets under management, including nearly €11 billion from third parties, invested in over 300 companies. With its considerable private equity, real estate, private debt and fund of funds expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its 235 professionals and by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term.
   Eurazeo has offices in Paris, New York, Sao Paulo, Buenos Aires, Shanghai, London, Luxembourg, Frankfurt and Madrid.

1. Eurazeo is listed on Euronext Paris.

1. ISIN: FR0000121121 - Bloomberg: RF FP - Reuters: EURA.PA

About C2S Group

1. C2S Group is a multi-regional group of clinics specializing in general medicine and a leader in Auvergne- Rhône-Alpes and Burgundy Franche-Comté, with 14 clinics. C2S Group is currently implementing a sustained acquisition strategy to provide uniform and consistent geographic coverage. Medical practitioners and health professionals in these two regions are closely involved with the Group, which adopts a sustainable and high- performing outlook to human health. It has developed a patient-centric health ecosystem and is committed to offering a comprehensive range of treatments, which anticipates the needs of each patient to provide healthcare excellence.

	EURAZEO CONTACTS		PRESS CONTACT
CAROLINE COHEN			VIRGINIE CHRISTNACHT		HAVAS PARIS
Head of Investor Relations			Head of Communications		MAEL EVIN
[e-mail]			[e-mail]		E-mail: [e-mail]
Tel.: [phone]				Tel: [phone]
		Tel: [phone]

For more information, please visit the Group's website: www.eurazeo.com

Follow us on Twitter, LinkedIn, and YouTube